Brief: Rubicon Research Says US FDA Conducts Unannounced Inspection Of Pithampur Facility
BRIEF-Rubicon Research Says US FDA Conducts Unannounced Inspection Of Pithampur Facility July 3 (Reuters) - Rubicon Research Ltd RUBI.NS:
RUBICON RESEARCH - US FDA CONDUCTS UNANNOUNCED INSPECTION OF PITHAMPUR FACILITY FROM JUNE 29 TO JULY 3, 2026
RUBICON RESEARCH - FORM 483 WITH 2 PROCEDURAL OBSERVATIONS ISSUED; NO DATA INTEGRITY ISSUES
Source text: ID:nBSE9SLh7G
Further company coverage: RUBI.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Rubicon Research
See all newsBrief: Rubicon Research Says USFDA Issues Form 483 With 1 Observation To Co's Satara Facility
Brief: General Atlantic Sells 13 Million Shares Of Rubicon Research Via Bulk Deal
India's Rubicon Research rises on quarterly profit, revenue jump
Brief: Rubicon Research June-Quarter Consol Net Profit 847.8 Million Rupees
Four Indian stocks to be added, three removed from key global index in MSCI's August rejig